Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
Appointed director
Inv. presentation
Auditor change
CC transcript
QUESTCOR PHARMACEUTICALS INC (QCOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/20/2014 8-K Form 8-K - Current report
08/14/2014 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "MALLINCKRODT AND QUESTCOR SHAREHOLDERS APPROVE MALLINCKRODT'S ACQUISITION OF QUESTCOR DUBLIN, IRELAND and ANAHEIM, Calif., Aug. 14, 2014 — Mallinckrodt plc and Questcor Pharmaceuticals, Inc. today jointly announced that all proposals necessary for Mallinckrodt's acquisition of Questcor were approved by Mallinckrodt's and Questcor's shareholders at each company's respective shareholder meeting held today. As previously announced, on April 7, 2014, Mallinckrodt and Questcor entered into a definitive agreement by which Mallinckrodt will acquire Questcor. Under the terms of the transaction, Questcor shareholders will receive $30.00 in cash and 0.897 of a Mallinckrodt ordinary share for each Questcor share. Mallinckrodt expects to close the transaction later today and subsequently issue a press..."
07/29/2014 8-K Other Events
07/25/2014 8-K Quarterly results
Docs: "Questcor Reports Record Second Quarter Financial Results"
07/10/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Revisions, where applicable, to the 2013 Form 10-K include: • Part I, Item 1. Business • Part I, Item 1A. Risk Factors • Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations"
05/15/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/05/2014 8-K Quarterly results
Docs: "Questcor Reports First Quarter Financial Results"
04/07/2014 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Mallinckrodt plc, Quincy Merger Sub, Inc. and Questcor Pharmaceuticals, Inc. (schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K)",
"MALLINCKRODT PHARMACEUTICALS AND QUESTCOR PHARMACEUTICALS ENTER INTO DEFINITIVE MERGER AGREEMENT UNDER WHICH MALLINCKRODT WILL ACQUIRE QUESTCOR FOR APPROXIMATELY $5.6 BILLION, CREATING A DIVERSIFIED, HIGH-GROWTH SPECIALTY PHARMACEUTICALS COMPANY"
03/03/2014 8-K Quarterly results, Conference call transcript
Docs: "Questcor Reports Fourth Quarter and Full Year 2013 Financial Results - Fourth Quarter Net Sales $243 Million; Increase 51% Year-over-Year - - Fourth Quarter GAAP EPS of $1.44, Non-GAAP EPS of $1.67 up 53% -",
"Transcript of conference call held on February 25, 2014",
"Presentation slides used during conference call held on February 25, 2014"
03/03/2014 8-K Regulation FD Disclosure
02/11/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Arrangement with Mr. Asarpota",
"Questcor Pharmaceuticals Expands Senior Management Team"
01/23/2014 8-K Other Events
01/13/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals, Inc. Investor Presentation"
01/13/2014 8-K Regulation FD Disclosure
12/11/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals, Inc. Investor Presentation"
12/11/2013 8-K Regulation FD Disclosure
11/13/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Questcor Adds G. Kelly Martin to Board of Directors"
11/04/2013 8-K Form 8-K - Current report
10/07/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals, Inc. Website Letter"
08/06/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals, Inc. Investor Presentation"
06/11/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Questcor Pharmaceuticals Acquires Rights to Synacthen ® - Expands Questcor's Presence in Inflammatory and Autoimmune Disorders - - Provides Foundation for Next Generation Melanocortin Receptor Agonist Therapeutics - - Initiates Global Footprint, Diversifies Business, Enhances Long-term Growth Prospects -"
06/11/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Questcor Adds Angus C. Russell to Board of Directors"
05/06/2013 8-K Quarterly results, Conference call transcript
Docs: "Questcor Reports First Quarter Financial Results - Net Sales Increase 41% Year Over Year; Down Sequentially - - April Vial Shipments Rebound Significantly Establishing a New Monthly Record - - Prescription Levels in Rheumatology Increasing - - Phase 2 Clinical Trial of Acthar in ALS to Start under FDA Accepted IND -",
"Transcript of conference call held on April 30, 2013",
"Presentation slides used during conference call held on April 30, 2013"
03/04/2013 8-K Quarterly results
Docs: "Questcor Reports Fourth Quarter and Full Year 2012 Results - Net Sales, EPS and Cash Flow from Operations Increase Significantly Over Prior Year Period - - Continues to Expand R&D Efforts - - Increases Quarterly Dividend 25% to $0.25 per share -",
"QUESTCOR PHARMACEUTICALS FOURTH QUARTER 2012 FINANCIAL RESULTS",
"40 35 30 25 20 15 10 5 0 2007 2008 2009 2010 2011 2012 80 70 60 50 40 30 20 10 0 2007 2008 2009 2010 2011 2012 4.8 10.6 10.9 9.7 16.8 34.3 0 2 33 34 20"
01/18/2013 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
01/04/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
10/25/2012 8-K Quarterly results, Conference call transcript
Docs: "Questcor Reports Third Quarter Financial Results",
"Transcript of conference call held on October 23, 2012",
"Presentation slides used during conference call held on October 23, 2012"
10/09/2012 8-K Form 8-K - Current report
09/28/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock Repurchase Program"
09/24/2012 8-K Other Events
09/19/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "QUESTCOR PHARMACEUTICALS, INC. PRESS RELEASE DATED SEPTEMBER 19, 2012."
09/10/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Questcor Pharmaceuticals, Inc. Investor Presentation"
09/07/2012 8-K Regulation FD Disclosure
09/04/2012 8-K Regulation FD Disclosure
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy